ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice

Patients with advanced-stage non-small cell lung carcinoma (NSCLC) harboring an ALK rearrangement, detected from a tissue sample, can benefit from targeted ALK inhibitor treatment. Several increasingly effective ALK inhibitors are now available for treatment of patients. However, despite an initial...

Descripción completa

Detalles Bibliográficos
Autor principal: Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575610/
https://www.ncbi.nlm.nih.gov/pubmed/28805682
http://dx.doi.org/10.3390/cancers9080107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575610/
https://www.ncbi.nlm.nih.gov/pubmed/28805682
http://dx.doi.org/10.3390/cancers9080107

Ejemplares similares